Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Akassoglou, K., Probert, L., Kontogeorgos, G., Kollias, G. (1997) Astrocyte-specific but not neuron-specific transmembrane TNF triggers inflammation and degeneration in the central nervous system of transgenic mice. J. Immunol. 158:348–445.
Arnason, B. G. W., Waksman, B. H. (1980) Immunoregulation in multiple sclerosis. Ann. Neurol. 8:237–240.
Babbe, H., Roers, A., Waisman, A., et al. (2000) Clonal expansion of CD8+ T cells dominate the T cell infiltrate in active multiple sclerosis lesions shown by micromanipulation and single cell polymerase chain reaction. J. Exp. Med. 192:393–404.
Bach, J-F. (2002) The effect of infections on susceptibility to autoimmune and allergic diseases. N. Engl. J. Med. 347:911–920.
Barnett, M. H., Prineas, J. W. (2004) Relapsing and remitting multiple sclerosis: pathology of the newly forming lesion (p NA). Ann. Neurol. 55:458–468.
Bielekova, B., Goodwin, B., Richert, N., et al. (2000) Encephalitogenic potential of the myelin basic protein peptide (amino acids 83–99) in multiple sclerosis: results of a phase II clinical trial with an altered peptide ligand. Nat. Med. 6:1167–1175.
Booss, J., Esiri, M. M., Tourtellotte, W. W., Mason, D. Y. (1983) Immunohistochemical analysis of T lymphocyte subsets in the central nervous system in chronic progressive multiple sclerosis. J. Neurol. Sci. 62:219–232.
Compston, A., Lassmann, H., McDonald, I. (2006) The story of multiple sclerosis. In: Compston, A., Confavreux, C., Lassmannn H., et al. (eds) McAlpine’s Multiple Sclerosis. Churchill Livingstone Elsevier, New York, pp 3–62.
Confavreux, C., Compston, A. (2006) The natural history of multiple sclerosis. In: Compston, A., Confavreux, C., Lassman, H. (eds) McAlpine’s Multiple Sclerosis. Churchill Livingstone Elsevier, New York, pp 183–272.
Droege, W. (1971) Amplifying and suppressive effect of thymus cells. Nature 234:549–551.
Ebers, G. C., Bulman, D. E., Sadovnick, A. D., et al. (1986) A population-based study of multiple sclerosis in twins. N. Engl. J. Med. 315:1638–1642.
Ellmerich, S., Mycko, M., Takács, K., et al. (2005) High incidence of spontaneous disease in an HLA-DR15 and TCR transgenic multiple sclerosis model. J. Immunol. 174:1938–1946.
Esiri, M. M. (1980) Multiple sclerosis: a quantitative and qualitative study of immunoglobulin-containing cells in the central nervous system. Neuropathol. Appl. Neurobiol. 6:9–21.
Friese, M. A., Fugger, L. (2005) Autoreactive CD8+ T cells in multiple sclerosis: a new target for therapy? Brain 128:1747–1763.
Genain, C. P., Lee-Parritz, D., Nguyen, M-H., et al. (1994) In healthy primates, circulating autoreactive T cells mediate autoimmune disease. J. Clin. Invest. 94:1339–1345.
Genain, C. P., Cannella, B., Hauser, S. L., Raine, C. S. (1999) Identification of autoantibodies associated with myelin damage in multiple sclerosis. Nat. Med. 5:170–175.
Gershon, R. K., Kondo K. (1971) Infectious immunological tolerance. Immunology 21:903–914.
Gilden, D. H. (1999) Chlamydia: a role for multiple sclerosis or more confusion? Ann. Neurol. 46:4–5.
Haas, J., Hug, A., Viehöver, A., et al. (2005) Reduced suppressive effect of CD4+CD25high regulatory T cells on the T cell immune response against myelin oligodendrocyte glycoprotein in patients with multiple sclerosis. Eur. J. Immunol. 35:3343–3352.
Hansen, T., Skytthe, A., Stenager, E., et al. (2005) Risk for multiple sclerosis in dizygotic and monozygotic twins. Mult. Scler. 11:500–503.
Haubold, K., Owens, G. P., Kaur, P., et al. (2004) B-lymphocyte and plasma cell clonal expansion in monosymptomatic optic neuritis cerebrospinal fluid. Ann. Neurol. 56:97–107.
Hauser, S. L., Bhan, A. K., Gilles, F., et al. (1986) Immunohistochemical analysis of the cellular infiltrate in multiple sclerosis lesions. Ann. Neurol. 19:578–587.
Hu, D., Ikizawa, K., Lu, L. R., et al. (2004) Analysis of regulatory CD8 T cells in Qa-1-deficient mice. Nat. Immunol. 5:516–523.
Huan, J., Culbertson, N., Spencer, L., et al. (2005) Decreased FOXP3 levels in multiple sclerosis patients. J. Neurosci. Res. 81:45–52.
Huseby, E. S., Liggitt, D., Brabb, T., et al. (2001) A pathogenic role for myelin specific CD8+ T cells in a model for multiple sclerosis. J. Exp. Med. 194:669–676.
Jacobson, E. B., Herzenberg, L. A., Riblet, R., Herzenberg, L. A. (1972) Active suppression of immunoglobulin allotype synthesis. II. Transfer of suppressing factor with spleen cells. J. Exp. Med. 135:1163–1176.
Jiang, H., Zhang, S-L., Pernis, B. (1992) Role of CD8+ T cells in murine experimental allergic encephalomyelitis. Science 256:1213–1215.
Jiang, H., Ware, R., Stall, A., et al. (1995) Murine CD8+ T cells that specifically delete autologous CD4+ T cells expressing Vb8 TCR: a role of the Qa-1 molecule. Immunity 2:185–194.
Jiang, H., Kashleva, H., Xu, L-X., et al. (1998) T cell vaccination induces T cell receptor Vb-specific Qa-1 restricted CD8+ T cells. Proc. Natl. Acad. Sci. USA 95:4533–4537.
Jiang, H., Curran, S., Ruiz-Vazquez, E., et al. (2003) Regulatory CD8+ T cells fine-tune the myelin basic protein-reactive T cell receptor Vb repertoire during experimental autoimmune encephalomyelitis. Proc. Natl. Acad. Sci. USA 100:8378–8383.
Kappos, L., Comi, G., Panitch, H., et al. (2000) Induction of a non-encephalitogenic Th2 autoimmune response in multiple sclerosis after administration of an altered peptide ligand in a placebo controlled, randomized phase II trial. Nat. Med. 6:1176–1182.
Keegan, M., König, F., McClelland, R., et al. (2005) Relation between humoral pathological changes in multiple sclerosis and response to therapeutic plasma exchange. Lancet 366:579–582.
Kira, J-I. (2003) Multiple sclerosis in the Japanese population. Lancet Neurol. 2:117–127.
Koh, D-R., Fung-Leung, W-P., Ho, A., et al. (1992) Less mortality but more relapses in experimental allergic encephalomyelitis in CD8-/- mice. Science 256:1210–1213.
Krumbholz, M., Theil, D., Derfuss, T., et al. (2005) BAFF is produced by astrocytes and upregulated in multiple sclerosis lesions and primary central nervous system lymphoma. J. Exp. Med. 201:195–200.
Krumbholz, M., Theil, D., Cepok, S., et al. (2006) Chemokines in multiple sclerosis: CXCL12 and CXCL13 up-regulation is differentially linked to CNS immune cell recruitment. Brain 129:200–211.
Kurtzke, J. F., Hyllested, K., Heltberg, A. (1995) Multiple sclerosis in the Faroe islands: transmission across four epidemics. Acta Neurol. Scand 91:321–325.
Lassmann, H., Wekerle, H. (2006) The pathology of multiple sclerosis. In: Compston, A., Confavreux, C., Lassmann, C., et al. (eds) McAlpine’s Multiple Sclerosis. Churchill Livingstone Elsevier, New York, pp 557–600.
Lassmann, H., Brück, W., Lucchinetti, C. (2001) Heterogeneity of multiple sclerosis pathogenesis: implications for diagnosis and therapy. Trends Mol. Med. 7:115–121.
Lehmann, P. V., Forsthuber, T., Miller, A., Sercarz, E. E. (1992) Spreading of T-cell autoimmunity to cryptic determinants of an autoantigen. Nature 358:155–157.
Lider, O., Reshef, T., Béraud, E., et al. (1988) Anti-idiotypic network induced by T-cell vaccination against experimental autoimmune encephalomyelitis. Science 239:181–183.
Lindå, H., Hammarberg, H., Cullheim, S., et al. (1998) Expression of MHC class I and b2-microglobulin in rat spinal motoneurons: regulatory influences of IFN-gamma and axotomy. Exp. Neurol. 150:282–295.
Madsen, L. S., Andersson, E. C., Jansson, L., et al. (1999) A humanized model for multiple sclerosis using HLA DR2 and a human T cell receptor. Nat. Genet. 23:343–347.
Magliozzi, R., Columba-Cabezas, S., Serafini, B., Aloisi, F. (2004) Intracerebral expression of CXCL13 and BAFF is accompanied by formation of lymphoid follicle-like structures in the meninges of mice with relapsing experimental autoimmune encephalomyelitis. J. Neuroimmunol. 148:11–23.
Martin, R., Jaraquemada, D., Flerlage, M., et al. (1990) Fine specificity and HLA restriction of myelin basic protein-specific cytotoxic T cell lines from multiple sclerosis patients and healthy individuals. J. Immunol. 145:540–548.
Medana, I., Martinic, M. M. A., Wekerle, H., Neumann, H. (2001) Transection of MHC class I-induced neurites by cytotoxic T lymphocytes. Am. J. Pathol. 159:809–815.
Meinl, E., Hoch, R. M., Dornmair, K., et al. (1997) Encephalitogenic potential of myelin basic protein-specific T cells isolated from normal rhesus macaques. Am. J. Pathol. 150:445–453.
Meinl, E., Krumbholz, M., Hohlfeld, R. (2006) B lineage cells in the inflammatory CNS environment: migration, maintenance, local antibody production and therapeutic modulation. Ann. Neurol. 59:880–892.
Mosser, J., Douar, A-M., Sarde, C-O., et al. (1993) Putative X-linked adrenoleukodystrophy gene shares unexpected homology with ABC transporters. Nature 361:726–730.
Najafian, N., Chitnis, T., Salama, A. D., et al. (2003) Regulatory functions of CD8+CD28-T cells in an autoimmune disease model. J. Clin. Invest. 112:1037–1048.
Neumann, H., Wekerle, H. (1998) Neuronal control of the immune response in the central nervous system: linking brain immunity to neurodegeneration. J. Neuropathol. Exp. Neurol. 58:1–9.
Neumann, H., Cavalié, A., Jenne, D. E., Wekerle, H. (1995) Induction of MHC class I genes in neurons. Science 269:549–552.
Nino-Vasquez, J. J., Allicotti, G., Borras, E., et al. (2005) A powerful combination: the use of positional scanning libraries and biometrical analysis to identify cross-reactive T cell epitopes. Mol. Immunol. 40:1063–1074.
O’Connor, K. C., Appel, H., Bregoli, L., et al. 2005. Antibodies from inflamed central nervous system tissue recognize myelin oligodendrocyte glycoprotein. J. Immunol. 175:1974–1982.
Oksenberg, J. R., Stuart, S., Begovich, A. B., et al. (1990) Limited heterogeneity of rearranged T-cell receptor Va transcripts in brains of multiple sclerosis patients. Nature 345:344–346.
Owens, G. P., Kraus, H., Burgoon, M. P., et al. (1998) Restricted use of VH4 germline segments in an acute multiple sclerosis brain. Ann. Neurol. 43:236–243.
Pette, M., Fujita, K., Wilkinson, D., et al. (1990) Myelin autoreactivity in multiple sclerosis: recognition of myelin basic protein in the context of HLA-DR2 products by T lymphocytes of multiple sclerosis patients and healthy donors. Proc. Natl. Acad. Sci. USA 87:7968–7972.
Powers, J. M., Moser, H. (1998) Peroxisomal disorders: genotype, phenotype, major neuropathologic lesions, and pathogenesis. Brain Pathol. 8:109–120.
Qin, Y., Duquette, P., Zhang, Y., et al. (1998) Clonal expansion and somatic hypermutation of VH genes of B cells from cerebrospinal fluid in multiple sclerosis. J. Clin. Invest. 102:1045–1050.
Sakaguchi, S. (2005) Naturally arising Foxp3-expressing CD4+CD25+ regulatory T cells in immunological tolerance to self and non-self. Nat. Immunol. 6:345–352.
Sibley, W. A., Bamford, C. R., Clark, K. (1985) Clinical viral infections and multiple sclerosis. Lancet 1:1313–1315.
Skulina, C., Schmidt, S., Dornmair, K., et al. (2004) Multiple sclerosis: brain-infiltrating CD8+ T cells persist as clonal expansions in the cerebrospinal fluid and blood. Proc. Natl. Acad. Sci. USA 101:2428–2433.
Sospedra, M., Martin, R. (2005) Immunology of multiple sclerosis. Annu. Rev. Immunol. 23:683–747.
Storch, M. K., Piddlesden, S., Haltia, M., et al. (1998a) Multiple sclerosis: in situ evidence for antibody- and complement-mediated demyelination. Ann. Neurol. 43:465–471.
Storch, M. K., Stefferl, A., Brehm, U., et al. (1998b) Autoimmunity to myelin oligodendrocyte glycoprotein in rats mimics the spectrum of multiple sclerosis pathology. Brain Pathol. 8:681–694.
Stüve, O., Cepok, S., Eliaset B., et al. (2005) Clinical stabilization and effective B-lymphocyte depletion in the cerebrospinal fluid and peripheral blood of a patient with fulminant relapsing-remitting multiple sclerosis. Arch. Neurol. 62:1620–1623.
Sun, D., Ben-Nun, A., Wekerle, H. (1988a) Regulatory circuits in autoimmunity: recruitment of counter-regulatory CD8+ T cells by encephalitogenic CD4+ T line cells. Eur. J. Immunol. 18:1993–2000.
Sun, D., Qin, Y., Chluba, J., et al. (1988b) Suppression of experimentally induced autoimmune encephalomyelitis by cytolytic T-T cell interactions. Nature 332:843–845.
Sun, D. M., Whitaker, J. N., Huang, Z. G., et al. (2001) Myelin antigen-specific CD8+ T cells are encephalitogenic and produce severe disease in C57BL/6 mice. J. Immunol. 166:7579–7587.
Tourtellotte, W. W., Staugaitis, S. M., Walsh, M. J., et al. (1985) The basis of intra-blood-brain-barrier IgG synthesis. Ann. Neurol. 17:21–27.
Ulmanen, I., Halonen, M., Ilmarinen, T., Peltonen, L. (2005) Monogenic autoimmune diseases—lessons of self-tolerance. Curr. Opin. Immunol. 17:609–615.
Vanderlugt, C. L., Miller, S. D. (2002) Epitope spreading in immune mediated diseases: implications for immunotherapy. Nat. Rev. Immunol. 2:85–95.
Viglietta, V., Baecher-Allan, C., Weiner, H. L., Hafler, D. A. (2004) Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis. J. Exp. Med. 199:971–979.
Wekerle, H. (2006) Breaking tolerance: the case of the brain. In: Radbruch, A., Lipsky, P. E. (eds) Current Concepts in Autoimmunity and Chronic Inflammation. Springer, Berlin, pp 25–50.
Woodroofe, M. N., Bellamy, A. S., Feldmann, M., et al. (1986) Immunocytochemical characterization of the immune reaction in the central nervous system in multiple sclerosis: possible role for microglia in lesion growth. J. Neurol. Sci. 74:135–152.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2007 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Wekerle, H. (2007). Multiple Sclerosis: Future Directions and Prospects. In: Zhang, J. (eds) Immune Regulation and Immunotherapy in Autoimmune Disease. Springer, Boston, MA. https://doi.org/10.1007/978-0-387-36003-4_22
Download citation
DOI: https://doi.org/10.1007/978-0-387-36003-4_22
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-387-36002-7
Online ISBN: 978-0-387-36003-4
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)